How did the reported earnings per share compare to analyst consensus estimates? | ADUS (Aug 06, 2025) | Candlesense
ADUS

How did the reported earnings per share compare to analyst consensus estimates?

Answer

The press release you quoted reports the following earnings‑per‑share (EPS) figures for Addus HomeCare ( NASDAQ: ADUS) for the second quarter of 2025:

Metric Value
Net income per diluted share $1.20
Adjusted net income per diluted share $1.49 (up 10.4% YoY)

However, the release does not include any reference to analyst expectations, such as the consensus‑forecasted EPS (either the “raw” or “adjusted” figure) that Wall Street analysts had compiled before the results were announced. Because the news article does not provide the analysts’ consensus estimate, we cannot determine from this source whether the reported $1.20 (or $1.49 adjusted) EPS was above, in line with, or below the analysts’ expectations.

What you would need to answer the question definitively

To compare the reported EPS to analyst consensus estimates, you would need one of the following pieces of information that is not present in the provided release:

  1. Consensus‑estimate EPS (raw or adjusted) published by a data‑provider such as FactSet, Bloomberg, Thomson Reuters, or S&P Capital IQ.
  2. A statement in the press release that says, for example, “Our EPS of $1.20 beat analysts’ consensus estimate of $1.07” or “missed the consensus estimate of $1.25.”
  3. A third‑party news article or analyst commentary that references the consensus estimate.

Conclusion

Based solely on the information you supplied, we can only state the company’s reported EPS figures; we cannot assess how those figures compare to analyst consensus estimates because the necessary estimate data is not included in the news release. If you can locate the consensus‑estimate numbers from a financial data service or another news source, you could then directly compare them to the $1.20 (raw) and $1.49 (adjusted) EPS reported by Addus HomeCare.

Other Questions About This News

Are there any upcoming regulatory changes or reimbursement policy shifts that could affect future revenue or margins? How did the adjusted EBITDA margin change versus the prior quarter and year‑over‑year? How did the adjusted net income per diluted share growth (10.4%) compare to the growth of net service revenue (21.8%)? How does the cash flow from operations compare to the prior quarter and to the company’s cash conversion ratio target? Did the company provide revised guidance for FY 2025, and how does it compare to prior guidance and consensus expectations? How does Addus HomeCare’s revenue growth and margin profile compare with its main competitors in the home‑care sector? How sustainable is the 21.8% revenue growth given the company’s historical growth rates and market conditions? What are the key risks highlighted by management (e.g., staffing shortages, labor costs, or reimbursement pressure) that could affect future performance? What impact will the reported results have on the stock’s technical indicators (e.g., moving averages, volume trends) and likely short‑term price movement? What is the composition of the $43.9 million adjusted EBITDA (e.g., operating margin, depreciation, amortization, and non‑recurring items)? What is the current debt load and net leverage ratio after this quarter’s results? What is the expected impact on earnings per share in the next quarter and the full‑year outlook based on the current trajectory? What were the drivers behind the 21.8% revenue growth – new client acquisition, higher visit volume, or price increases? What is the company’s capital allocation plan—share buybacks, dividend increases, or reinvestment in growth—following this quarter’s performance? What was the YoY change in revenue and how much of it was organic versus acquisition driven?